Skip to main content
Journal cover image

Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark?

Publication ,  Journal Article
Gaillard, SL; Coleman, RL
Published in: Ann Oncol
July 1, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

July 1, 2019

Volume

30

Issue

7

Start / End Page

1025 / 1028

Location

England

Related Subject Headings

  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Humans
  • Female
  • B7-H1 Antigen
  • Antibodies, Monoclonal, Humanized
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gaillard, S. L., & Coleman, R. L. (2019). Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark? Ann Oncol, 30(7), 1025–1028. https://doi.org/10.1093/annonc/mdz166
Gaillard, S. L., and R. L. Coleman. “Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark?Ann Oncol 30, no. 7 (July 1, 2019): 1025–28. https://doi.org/10.1093/annonc/mdz166.
Gaillard SL, Coleman RL. Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark? Ann Oncol. 2019 Jul 1;30(7):1025–8.
Gaillard, S. L., and R. L. Coleman. “Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark?Ann Oncol, vol. 30, no. 7, July 2019, pp. 1025–28. Pubmed, doi:10.1093/annonc/mdz166.
Gaillard SL, Coleman RL. Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark? Ann Oncol. 2019 Jul 1;30(7):1025–1028.
Journal cover image

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

July 1, 2019

Volume

30

Issue

7

Start / End Page

1025 / 1028

Location

England

Related Subject Headings

  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Humans
  • Female
  • B7-H1 Antigen
  • Antibodies, Monoclonal, Humanized
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis